Table 2.
Therapies and clinical outcomes of included studies.
| Author Year | Therapies | Acupoints selection | Outcome |
| Bi 2011[25] | C:IAIG5 ml Guanxinning injection was injected into the hip joint cavity, twice a week for 12 weeks.T:IAIG+AMOn the basis of control group treatment, and combined with acupuncture treatment, 5 times a week (once a day) for 12 weeks | Zusanli (ST36), Huantiao (GB30), Sanyinjiao (SP6), Yanglingquan (GB34) | Effective rate; Excellent and good rate; Harris Hip Function Score |
| Guo 2015[28] | C:TCMTraditional Chinese medicine internal and conventional treatment for 2 months.T:TCM+AMOn the basis of control group treatment, combined with acupuncture and moxibustion, 5 times a week for 2 months | Huantiao (GB30), Huanzhong (extra point), Yanglingquan (GB34), Juliao (GB29), Xuanzhong (GB39) | Harris Hip Function Score; Effective rate; Visual Analogue Scale (VAS);Clinical efficacy standard (Cured, improved, not cured) according to Standards for diagnosis and treatment of traditional Chinese medicine |
| Hu 2016[27] | C: IAIG5 ml Guanxinning injection was injected into the hip joint cavity, twice a week for 3 months.T:IAIG+AMOn the basis of control group treatment, combined with acupuncture and moxibustion, 5 times a week for 3 months | Zusanli (ST36), Huantiao (GB30), Sanyinjiao (SP6), Yanglingquan (GB34) | Effective rate; excellent and good rate; hip joint function recovery time; incidence of related adverse reactions during treatment; total treatment time |
| Zhang 2018[26] | C: IAIG5 ml Guanxinning injection was injected into the hip joint cavity, twice a week for 3 months.T:IAIG+AMOn the basis of control group treatment, combined with acupuncture, 5 times a week for 3 months | Zusanli (ST36), Huantiao (GB30), Sanyinjiao (SP6), Yanglingquan (GB34) | Excellent and good rate; Harris Hip Function Score; Total treatment time; Hip joint function recovery time; Incidence of related adverse reactions during treatment |
| Jin 2019[30] | C: CDCore decompressionT: CD+EACombined electro-acupuncture after 2 weeks of core decompression for 3 months. | Juliao (GB29), Biguan (ST31), Xuehai (SP10), Fengshi (GB31), Zusanli (ST36), Yanglingquan (GB34), Weizhong (BL40), Sanyinjiao (SP6), Xuanzhong (GB39), Shenshu (BL23), Zhibian (BL54), Huantiao (GB30) | Effective rate; excellent and good rate; Harris hip function score; radiographic score |
| Li 2019[36] | C: IAIG5 ml Guanxinning injection was injected into the hip joint cavity, twice a week for 3 months.T:IAIG+AMOn the basis of control group treatment, combined with acupuncture, 5 times a week for 3 months | Not mentioned | Effective rate; Harris hip function score; incidence of related adverse reactions during treatment |
| Mo 2020[32] | C: OCoral Osteonecrosis Capsule, 5 capsules each time, 3 times a day for 2 months.T: OC+AMOn the basis of control group treatment, combined with acupuncture and moxibustion, 5 times a week for 2 months | Pain point, Huanzhong (extra point), Yanglingquan (GB34), Wuanzhong (GB39), Zusanli (ST36), Shenshu (BL23), Taixi (KI3), Xuehai (SP10), Sanyinjiao (SP6), Taichong (LR3) | Effective rate; excellent and good rate; plasma specific viscosity; ehole blood high shear viscosity; the volume of osteonecrosis; The grayscale of osteonecrosis area; the grayscale of femoral head |
| Mo 2020[31] | C: OCoral steonecrosis apsule, 5 capsules each time, 3 times a day, with regular exercise for 1 month. And in the next 2 months, change to 2 times a day.T: OC+IAOn the basis of control group treatment, combined with acupuncture and moxibustion, once a month for 3 months | Not mentioned | Effective rate; excellent and good rate; Harris hip function score; serum VEGF and BMP-2 levels; recurrence rate |
| Zhao 2020[29] | C: RTTraditional Chinese medicine comprehensive treatment.T: RT+AMOn the basis of control group treatment, combined with acupuncture, once a day for 1 month | Pain point, Dazhu (BL11), Yangfu (GB38), Neiting (ST44), Shangqiu (SP5), Xingjian (LR2), Taibai (SP3), Gongsun (SP4), Taichong (LR3), Neiting (ST44), Xiangu (ST43), Xiaxi (GB43), Diwuhui (GB42), Waiqiu (GB36), Zhongdu (LR6), Liangqiu (ST34), Jinmen (BL63), Yinlingquan (SP9), Zusanli (ST36), Lidui (ST45), Neiting (ST44), Zulinqi (GB41), Yanglingquan (GB34), Dadun (LR1) | Effective rate; clinical efficacy standard (cured, improved, not cured) according to Standards for diagnosis and treatment of traditional Chinese medicine |